VJHemOnc is committed to improving our service to you

iwCLL 2019 | BIRC3 loss accelerates leukemic progression in CLL

VJHemOnc is committed to improving our service to you

Miguel Quijada-Álamo

Miguel Quijada-Álamo, Universidad de Salamanca-CSIC, Hospital Universitario, Salamanca, Spain, talks about BIRC3 loss and the acceleration of leukemic progression in chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter